Article
Clinical Application of Next-Generation Sequencing-Based Panel to BRAF Wild-Type Advanced Melanoma Identifies Key Oncogenic Alterations and Therapeutic Strategies.
Molecular cancer therapeutics - 1 Mar 2020
Park Changhee, Kim Miso, Kim Min Jung, Kim Hyeongmin, Ock Chan-Young, Keam Bhumsuk, Kim Tae Min, Kim Dong-Wan, Kim Jong-Il, Heo Dae Seog
Abstract excerpt
Molecular profiling with next-generation sequencing (NGS) has been applied in multiple solid cancers to discover potential therapeutic targets. Here, we describe the results of a clinical NGS panel in patients with advanced melanoma. Thirty-six tumor tissues from patients with BRAF wild-type melanoma at Seoul National University Hospital (SNUH; Seoul, Republic of Korea) were collected and deep-sequenced using the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
